New MainStream Adds Constellation Behavioral
Constellation Behavioral Health, LLC became the fourth healthcare services company in New MainStream Capital’s portfolio on May 19. Constellation joins Anne Arundel Dermatology, MCCI Medical Group and Suncrest Home Health. Based in Mill Valley, California, Constellation offers specialized inpatient and outpatient treatment programs for addiction, mental health and co-occurring behavioral health disorders. Founder and CEO William Morrison will retain a minority stake. Constellation operates two facilities in California: Alta Mira and Bridges to Recovery. Alta Mira is a 30-bed facility in Sausalito, California with 30,000 square feet. Bridges to Recovery is a 12-bed facility in Los... Read More »PE Firms Are Big on Dermatology
Dermatology deals are popping up like, well, you can imagine. Five acquisitions have been announced in May 2016 alone, bringing this year’s total dermatology deals to nine, and equal to the number announced in all of 2014. Those nine deals put this year on track to surpass 2015’s total of 11 deals. Private equity firms or their portfolio companies are by far the busiest players buying up dermatology clinics, accounting for 88% of acquisitions in this space since 2014. Finding a decent-size platform is a tough task in health care these days, as panelists at a recent health care deal summit noted. Outpatient physical therapy, behavioral health care, anesthesia practices are all in play. But... Read More »Mylan Adds Topical Pharmaceuticals Business
Mylan NV (NASDAQ: MYL) still has money to spend, following its $9.9 billion deal for Swedish drug maker Meda AB in February. On Friday, May 13, RoundTable Healthcare Partners announced that its portfolio company, Renaissance Acquisition Holdings, LLC, had agreed to sell its non-sterile topical drug business to Mylan for $950 million, plus additional contingent payments of up to $50 million. The topical division is a specialty pharmaceutical business focused on manufacturing, developing, sales and marketing of branded and generic drug products. The acquisition brings a complementary portfolio of approximately 25 branded and generic topical products, an active pipeline of approximately 25... Read More »Reporter’s Notebook: PE Healthcare Investor Forum 2016
The first-ever Private Equity Healthcare Investor Forum took place in New York City on April 27, 2016 at the Westin Times Square. We were invited to attend by the sponsor, Private Equity International. The conference was originally planned to span two days, but was cut down to a single, panel-crammed event a few weeks before. Attendance was spotty, and at times it seemed the bulk of the audience were all speakers. Don’t get us wrong, we’d go again, if invited. The most interesting panel, in our opinion, was moderated by Richard Zall, partner and chair of Proskauer’s Health Care Department. Titled “When healthcare meets private equity: analyzing investor trends and... Read More »Four More Behavioral Health Deals in May
Mergers and acquisitions in the behavioral health care sector have picked up significantly in April and May. Although only eight deals were announced in the first quarter of 2016, nine more have come along in just the past six weeks. Four have been announced in the first 10 days of May, beginning with Acadia Healthcare Company (NASDAQ: ACHC) and its acquisition of TrustPoint Hospital in Murfreesboro, Tennessee from privately-held Polaris Hospital Company. TrustPoint is a 129-bed facility, and since the deal closed on May 1, Acadia has filed a certificate of need for another 100 beds. Moving north to Buffalo, New York, two not-for-profits merged to become one of the largest community-based... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
